Y-Intercept (Hong Kong) Ltd
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1772875
HONG KONG, K3
Position in SUPN
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$1,045,998
+$194,140 QoQ
Shares Held
20,236
+18.1% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Y-Intercept (Hong Kong) Ltd holds $31,681,893 across 15 Drug Manufacturers - Specialty & Generic names. SUPN ranks #6 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
302,995 | $9,126,209 | |
| 2 | VTRS |
Viatris Inc
|
525,863 | $7,104,409 | |
| 3 | PRGO |
PERRIGO Co plc
|
447,451 | $4,805,623 | |
| 4 | BIOA |
BioAge Labs, Inc.
|
201,337 | $3,521,384 | |
| 5 | ZTS |
Zoetis Inc.
|
15,837 | $1,872,091 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
20,236 | $1,045,998 | |
| 7 | HLN |
Haleon plc
|
93,822 | $939,158 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
161,793 | $938,399 |
All Filings in SUPN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,045,998 | 20,236 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $851,858 | 17,140 | Shares | Sole | 2026-02-13 | |
| 2023-09-30 | $444,731 | 16,131 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||